The global anti-inflammatory therapeutics market is projected to reach a valuation of approximately USD 165.3 billion by 2033, up from USD 104.1 billion in 2023, with a compound annual growth rate (CAGR) of 7.6% anticipated during the forecast period of 2023 to 2033